Emergent BioSolutions SEC Filings
NYSE: EBSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.06+0.25 (+3.67%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Emergent BioSolutions filing overview
This page lists 1 recent SEC filings by Emergent BioSolutions (EBS), including 1 4. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
EBS SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Oct 7, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |